Tolfenamic acid suppresses inflammatory stimuli-mediated activation of NF-κB signaling

Biomolecules and Therapeutics

Volumn 23, Issue 1, 2015, Pages 39-44

  Shao, Hong Jun ^a,b   Lou, Zhiyuan ^a   Jeong, Jin Boo ^c   Kim, Kui Jin ^a   Lee, Jihye ^a   Lee, Seong Ho ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b SHAANXI NORMAL UNIVERSITY   (China)

^c Andong National University   (South Korea)

Author keywords

Inflammation; NF kappa B; Tolfenamic acid

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TOLFENAMIC ACID;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REPRESSION; HCT116 CELL LINE; HEK293 CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAW 264.7 CELL LINE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84982764494     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2014.088     Document Type: Article

References (21)

1. Abdelrahim, M., Baker, C. H., Abbruzzese, J. L., and Safe, S. (2006) Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. J. Natl. Cancer. Inst. 98, 855-868
2. Bergman, M., Djaldetti, M., Salman, H., and Bessler, H. (2011) Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells? Inflammation 34, 22-28
3. Corell, T. (1994) Pharmacology of tolfenamic acid. Pharmacol. Toxicol. 75 Suppl 2, 14-21
4. Din, F. V., Stark, L. A., and Dunlop, M. G. (2005) Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency. Br. J. Cancer 92, 1137-1143
5. Dvoriantchikova, G., and Ivanov, D. (2014) Tumor necrosis factoralpha mediates activation of NF-kappaB and JNK signaling cascades in retinal ganglion cells and astrocytes in opposite ways. Eur. J. Neurosci. 40, 3171-3178
6. Eslin, D., Sankpal, U. T., Lee, C., Sutphin, R. M., Maliakal, P., Currier, E., Sholler, G., Khan, M., and Basha, R. (2013) Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma. Mol. Carcinog. 52, 377-386
7. Jeong, J. B., Choi, J., Baek, S. J., and Lee, S. H. (2013a) Reactive oxygen species mediate tolfenamic acid-induced apoptosis in human colorectal cancer cells. Arch. Biochem. Biophys. 537, 168-175
8. Jeong, J. B., Shin, Y. K., and Lee, S. H. (2013b) Anti-inflammatory activity of patchouli alcohol in RAW264.7 and HT-29 cells. Food Chem. Toxicol. 55, 229-233
9. Jeong, J. B., Yang, X., Clark, R., Choi, J., Baek, S. J., and Lee, S. H. (2013c) A mechanistic study of the proapoptotic effect of tolfenamic acid; involvement of NF-kappaB activation. Carcinogenesis 34, 2350-2360
10. Kang, S. U., Shin, Y. S., Hwang, H. S., Baek, S. J., Lee, S. H., and Kim, C. H. (2012) Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: involvement of NAG-1 expression. PLoS One 7, e34988
11. Kankaanranta, H., Moilanen, E., and Vapaatalo, H. (1991) Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro. Inflammation 15, 137-143
12. Kopp, E., and Ghosh, S. (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265, 956-959
13. Lamb, J. A., Ventura, J. J., Hess, P., Flavell, R. A., and Davis, R. J. (2003) JunD mediates survival signaling by the JNK signal transduction pathway. Mol. Cell 11, 1479-1489
14. Lee, S. H., Bahn, J. H., Whitlock, N. C., and Baek, S. J. (2010) Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways. Oncogene 29, 5182-5192
15. Liggett, J. L., Zhang, X., Eling, T. E., and Baek, S. J. (2014) Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenaseindependent targets. Cancer Lett. 346, 217-224
16. Paik, J. H., Ju, J. H., Lee, J. Y., Boudreau, M. D., and Hwang, D. H. (2000) Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways. J. Biol. Chem. 275, 28173-28179
17. Pathi, S., Li, X., and Safe, S. (2014) Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors. Mol. Carcinogenesis 53 Suppl 1, E53-E61
18. Proudman, K. E., and McMillan, R. M. (1991) Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclo-oxygenase? Agents Actions 34, 121-124
19. Stark, L. A., Din, F. V., Zwacka, R. M., and Dunlop, M. G. (2001) Aspirin- induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 15, 1273-1275
20. Stark, L. A., Reid, K., Sansom, O. J., Din, F. V., Guichard, S., Mayer, I., Jodrell, D. I., Clarke, A. R., and Dunlop, M. G. (2007) Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis 28, 968-976
21. Yin, M. J., Yamamoto, Y., and Gaynor, R. B. (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77-80.